Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Salatac Gel

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Lactic acid, Salicylic acid may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Lactic acid, Salicylic acid

Equivalent medicines (same active substance, strength and form)

→ Bazuka Gel brand

Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

How to take it

Salatac Gel 4. Possible side effects 5. How to store Salatac Gel

How to store it

SALATAC GEL

  • Keep out of the sight and reach of children.
  • Do not use Salatac Gel after the expiry date shown at the end of the tube and on the carton. The expiry date refers to the last day of that month.
  • Do not store above 25°C.
  • Always replace the cap tightly after use.
  • The product is highly flammable. Keep it away from flames or ignition sources.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION What Salatac Gel contains: The active ingredients are salicylic acid (12.0% w/w) and lactic acid (4.0% w/w). The other ingredients are camphor, pyroxylin (contains isopropyl alcohol as a damping solvent), ethanol and ethyl acetate. What Salatac Gel looks like and contents of the pack The product is a clear colourless gel. The product is available in a tube containing 8 g of gel. The tube has a special applicator nozzle. Each pack also includes an emery board. Marketing Authorisation holder Dermal Laboratories, Hitchin, Herts, SG4 7QR. Manufacturer Aeropak, Viking Road, Great Yarmouth, Norfolk, NR31 0NU, UK. This Leaflet was last revised in July 2025. To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only). Please be ready to give the following information: Salatac Gel, 00173/0046. This is a service provided by the Royal National Institute of Blind People (RNIB).

Like all medicines, Salatac Gel can cause side effects although not everybody gets them:

WP4/25/2 202874

Contents of the pack and other information

A. Soak the affected area in warm water for 2 to 3 minutes. B. Dry the area thoroughly, using your own towel if you have a wart or verruca (this will help stop the infection spreading to other people). C. Taking care to avoid squeezing the tube, remove the protective cap, leaving the nozzle attached to the tube.

D. Carefully apply a thin coating (one or two drops) of the gel to the top of the wart, verruca, corn or callus only:

  • avoid the gel spreading to the surrounding healthy skin;
  • allow the gel to dry for a few minutes to form a small white patch that sticks to the treated area and is water resistant;
  • there is no need to cover the treated area with a sticking plaster;
  • always replace the protective cap after use. E. The next evening, carefully peel or pick off the white patch of dried gel from the wart, verruca, corn or callus:
  • apply fresh gel as described in steps A to D above;
  • if removal of the white patch is difficult, carefully re-apply the gel directly over it and leave it to dry. This will thicken the white patch and make it easier to remove. F. Once every week, before applying fresh gel, gently rub the wart, verruca, corn or callus with the emery board provided, or a pumice stone:
  • if you are treating a wart or verruca, do not let anyone else use the emery board or pumice stone as the infection may spread to them. G. The length of treatment will vary depending on the size and resistance of the wart, verruca, corn or callus:
  • some may go in a relatively short time;
  • some warts and verrucas can require up to 12 weeks treatment before they disappear;
  • it is important that you do not give up on the treatment until the wart, verruca, corn or callus has disappeared (unless irritation occurs, see section 4 below);
  • if the wart, verruca, corn or callus has not disappeared after twelve weeks of treatment ask your doctor or pharmacist for advice. H. At the end of treatment, if the white patch is difficult to remove, you can leave it because it will eventually fall off by itself. If the gel accidentally gets onto normal skin, wipe it off straight away with a tissue, and, if necessary, wash the area. If the gel accidentally gets into the eyes or mouth, it may cause damage. Rinse the eyes or mouth with plenty of water. If rinsing one eye, take care to avoid washing product into the other eye. Then seek urgent hospital attention. If you inhale a lot of the vapour from the gel it may make you feel light-headed. If this happens, get plenty of fresh air. If you forget to use Salatac Gel Do not worry if you occasionally forget to use this product, just carry on using it when you remember. If you have any further questions on the use of this product, ask your doctor or pharmacist.
  • While the gel is working you may feel a slight tingling sensation and / or some mild tenderness at the treated area. This is usually temporary, and in rare cases may appear as a temporary blemish on the skin.
  • If you mistakenly allow the gel to spread onto and remain in contact with areas of normal skin (see precautions in section 2), it may cause irritation.
  • If you spill the product on your clothes, fabrics, jewellery or metal and polished surfaces it may damage them permanently. Stop using this product and tell your doctor
  •  or pharmacist if:
  • you experience unacceptable discomfort or if irritation persists, or;
  • any of the side effects get serious, or you notice any other side effects not mentioned in this leaflet. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

Frequently asked questions about Salatac Gel

How do I take Salatac Gel?

Salatac Gel comes as gel. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Salatac Gel?

The active substance in Salatac Gel is lactic acid, salicylic acid.

Are there equivalent medicines to Salatac Gel?

Medicines with the same active substance, strength and form include: Bazuka Gel, Bazuka Treatment Gel. They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Salatac Gel, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Salatac Gel without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Lactic acid, salicylic acid (3 medicines), Salicylic acid (21 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For the topical treatment of warts, verrucas, corns and calluses.

4.2. Posology and method of administration

For adults, children and the elderly.

Salatac Gel should be applied once daily. The gel should be applied once every night. Treatment can take up to twelve (12) weeks for resistant lesions to disappear, and it is necessary to persevere with the treatment.

1. Every night, soak the affected site in warm water for 2 to 3 minutes.

2. Dry thoroughly with the patient's own towel.

3. Carefully apply one or two drops of the gel to the lesion and allow to dry over its surface. Take care to avoid spreading on to surrounding normal skin. No adhesive plaster is necessary.

4. The following evening, carefully remove and discard the elastic film formed from the previous application, and reapply the gel. Occasionally, if removal of the elastic film proves difficult, carefully reapply the gel directly over it and allow to dry. This should help thicken the film to assist removal. If necessary, such re-application may be made on two or three successive days.

5. Once a week, gently rub away the treated surface using an emery board, as provided, or pumice stone used only for this purpose, before re-applying the gel.

6. The wart, verruca, corn or callus may take up to twelve (12) weeks to disappear and it is important to persevere with the treatment.

7. At the end of treatment, if the elastic film is difficult to remove, it may be allowed to remain on the skin until it sheds.

4.3. Contraindications

Not to be used on or near the face, intertriginous or anogenital regions, or by diabetics or individuals with impaired peripheral blood circulation. Not to be used on moles or on any other skin lesions for which the gel is not indicated.

Not to be used in cases of sensitivity to any of the ingredients.

4.4. Special warnings and precautions for use

Keep away from the eyes, mucous membranes and from cuts and grazes.

The gel should be applied carefully to the wart, verruca, corn or callus only, to avoid possible irritation of surrounding normal skin.

Do not use excessively.

Some mild, transient irritation may be expected, but in cases of more severe or persistent pain/irritation, the treatment should be suspended and/or discontinued. See also Section 4.8.

Avoid inhaling vapour, and keep cap firmly closed when not in use.

Contact with clothing, fabrics, plastics and other materials may cause damage, and should be avoided.

For external use only.

Keep all medicines out of the reach of children.

4.5. Interaction with other medicinal products and other forms of interaction

None known.

4.6. Fertility, pregnancy and lactation

There are no or limited amount of data from the use of Salatac Gel during pregnancy.

Salatac Gel should not be used during pregnancy, except for short-term treatment of a small single wart, verruca, corn or callus.

It is not known if the systemic Salatac Gel exposure reached after topical administration can be harmful to an embryo/fetus.

During the third trimester of pregnancy, systemic use of prostaglandin synthetase inhibitors may induce cardiopulmonary and renal toxicity in the fetus. At the end of the pregnancy prolonged bleeding time in both mother and child may occur, and labour can be delayed.

4.7. Effects on ability to drive and use machines

None known.

4.8. Undesirable effects

Salatac Gel may be irritant in certain patients, which in rare instances may appear as a temporary blemish on the skin. See also Section 4.4.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Any excessive use of Salatac Gel could cause irritation of the skin. If this occurs, Salatac Gel should be used more sparingly or applied less frequently.

💬 Ask about this leaflet

Ask anything about Salatac Gel. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Medicines containing Lactic acid, Salicylic acid

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →